Sildenafil (Generic Viagra®) 25mg-100mg

However, VIAGRA may be taken anywhere from

Route of administration

It is not possible to determine whether these events are related directly to the use of PDE5 inhibitors, to the patient's underlying vascular risk factors or anatomical defects, to a combination of these factors, or to other factors (see PRECAUTIONS/Information for Patients ). In studies with healthy volunteers of single doses up to 800 mg, adverse events were similar to those seen at lower doses but incidence rates and severities were increased. In cases of overdose, standard supportive measures should be adopted as required. Renal dialysis is not expected to accelerate clearance as sildenafil is highly bound to plasma proteins and it is not eliminated in the urine. For most patients, the recommended dose is 50 mg taken, as needed, approximately 1 hour before sexual activity. 4 hours to 0.5 hour before sexual activity.

Based on effectiveness and toleration, the dose may be increased to

a maximum recommended dose of 100 mg or decreased to 25 mg.

About the Company

There were three subjects who had a standing SBP of less than 85 mmHg. All three were taking VIAGRA 100 mg, and all three reported mild adverse events at the time of reductions in standing SBP, including vasodilation and lightheadedness. There were four subjects with a decrease from baseline in standing systolic BP greater than 30mmHg following VIAGRA 100 mg, one subject with a decrease from baseline in standing systolic BP greater than 30 mmHg following placebo and one subject with a decrease from baseline in standing systolic BP greater than 30 mmHg following both VIAGRA and placebo. While there were no severe adverse events potentially related to blood pressure reported in this study, one subject reported moderate vasodilatation after both VIAGRA 50 mg and 100 mg. There were no episodes of syncope reported in this study.

Does Viagra increase a man’s sex drive?

When VIAGRA 100 mg oral was coadministered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic. No significant interactions were shown with tolbutamide (250 mg) or warfarin (40 mg), both of which are metabolized by CYP2C9. VIAGRA (50 mg) did not potentiate the increase in bleeding time caused by aspirin (150 mg). VIAGRA (50 mg) did not potentiate the hypotensive effect of alcohol in healthy volunteers with mean maximum blood alcohol levels of 0.08%. In a study of healthy male volunteers, sildenafil (100 mg) did not affect the steady state pharmacokinetics of the HIV protease inhibitors, saquinavir and ritonavir, both of which are CYP3A4 substrates. The maximum recommended dosing frequency is once per day.

Further information

The nature of the adverse events in flexible-dose studies, which more closely reflect the recommended dosage regimen, was similar to that for fixed-dose studies. When VIAGRA was taken as recommended (on an as-needed basis) in flexible-dose, placebo-controlled clinical trials, the following adverse events were reported: Abnormal Vision: Mild and transient, predominantly color tinge to vision, but also increased sensitivity to light or blurred vision. In these studies, only one patient discontinued due to abnormal vision. Other adverse reactions occurred at a rate of greater than 2%, but equally common on placebo: respiratory tract infection, back pain, flu syndrome, and arthralgia. In fixed-dose studies, dyspepsia (17%) and abnormal vision (11%) were more common at 100 mg than at lower doses.

Generic Name

At doses above the recommended dose range, adverse events were similar to those detailed above but generally were reported more frequently. The following events occurred in less than 2% of patients in controlled clinical trials; a causal relationship to VIAGRA is uncertain. Reported events include those with a plausible relation to drug use; omitted are minor events and reports too imprecise to be meaningful: Body as a whole: face edema, photosensitivity reaction, shock, asthenia, pain, chills, accidental fall, abdominal pain, allergic reaction, chest pain, accidental injury. Metabolic and Nutritional: thirst, edema, gout, unstable diabetes, hyperglycemia, peripheral edema, hyperuricemia, hypoglycemic reaction, hypernatremia. Respiratory: asthma, dyspnea, laryngitis, pharyngitis, sinusitis, bronchitis, sputum increased, cough increased. The following factors are associated with

increased plasma levels of sildenafil: age

• The 25 mg dose can be part of a tailored treatment plan prescribed by your doctor.
• Some men might find 25 mg sufficient for achieving desired results.
• Always discuss any side effects or concerns with your healthcare provider.
• Viagra’s onset of action is usually within 30 to 60 minutes.
• Combining Viagra with high-fat meals can delay its effects.
• Age may influence the appropriate dosage of Viagra.
• Lifestyle factors, such as smoking, can impact Viagra's effectiveness.

greater than 65 (40% increase in

Mechanism of action

In the nonpregnant rat the AUC at this dose was about 20 times human AUC. There are no adequate and well-controlled studies of sildenafil in pregnant women. Healthy elderly volunteers (65 years or over) had a reduced clearance of sildenafil (see CLINICAL PHARMACOLOGY: Pharmacokinetics in Special Populations ). Since higher plasma levels may increase both the efficacy and incidence of adverse events, a starting dose of 25 mg should be considered (see DOSAGE AND ADMINISTRATION ). VIAGRA was administered to over 3700 patients (aged 19–87 years) during pre-marketing clinical trials worldwide.

Related treatment guides

Over 550 patients were treated for longer than one year. In placebo-controlled clinical studies, the discontinuation rate due to adverse events for VIAGRA (2.5%) was not significantly different from placebo (2.3%). The adverse events were generally transient and mild to moderate in nature. In trials of all designs, adverse events reported by patients receiving VIAGRA were generally similar. In fixed-dose studies, the incidence of some adverse events increased with dose. AUC), hepatic impairment (e.g., cirrhosis, 80%),

Who is Viagra suitable for?

Skin and Appendages: urticaria, herpes simplex, pruritus, sweating, skin ulcer, contact dermatitis, exfoliative dermatitis. Serious cardiovascular, cerebrovascular, and vascular events, including myocardial infarction, sudden cardiac death, ventricular arrhythmia, cerebrovascular hemorrhage, transient ischemic attack, hypertension, subarachnoid and intracerebral hemorrhages, and pulmonary hemorrhage have been reported post-marketing in temporal association with the use of VIAGRA. Most, but not all, of these patients had preexisting cardiovascular risk factors. Many of these events were reported to occur during or shortly after sexual activity, and a few were reported to occur shortly after the use of VIAGRA without sexual activity. Others were reported to have occurred hours to days after the use of VIAGRA and sexual activity.

Dosage questions

It is not possible to determine whether these events are related directly to VIAGRA, to sexual activity, to the patient's underlying cardiovascular disease, to a viagra jelly sachets uk combination of these factors, or to other factors (see WARNINGS for further important cardiovascular information). Cases of sudden decrease or loss of hearing have been reported postmarketing in temporal association with the use of PDE5 inhibitors, including VIAGRA. In some of the cases, medical conditions and other factors were reported that may have also played a role in the otologic adverse events. In many cases, medical follow-up information was limited. It is not possible to determine whether these reported events are related directly to the use of VIAGRA, to the patient's underlying risk factors for hearing loss, a combination of these factors, or to other factors (see PRECAUTIONS, Information for Patients ). severe renal impairment (creatinine clearance less

Who shouldn’t use Viagra tablets?

Other events reported post-marketing to have been observed in temporal association with VIAGRA and not listed in the clinical trial adverse reactions section above include: Nervous: seizure, seizure recurrence, anxiety, and transient global amnesia. Urogenital: prolonged erection, priapism (see WARNINGS ), and hematuria. Special Senses: diplopia, temporary vision loss/decreased vision, ocular redness or bloodshot appearance, ocular burning, ocular swelling/pressure, increased intraocular pressure, retinal vascular disease or bleeding, vitreous detachment/traction, paramacular edema and epistaxis. Non-arteritic anterior ischemic optic neuropathy (NAION), a cause of decreased vision including permanent loss of vision, has been reported rarely post-marketing in temporal association with the use of phosphodiesterase type 5 (PDE5) inhibitors, including VIAGRA. Most, but not all, of these patients had underlying anatomic or vascular risk factors for developing NAION, including but not necessarily limited to: low cup to disc ratio ("crowded disc"), age over 50, diabetes, hypertension, coronary artery disease, hyperlipidemia and smoking. than 30 mL/min, 100%), and concomitant

• Sildenafil 25 mg is a cornerstone of oral pharmacotherapy for erectile dysfunction.
• Its mechanism involves enhancing the natural nitric oxide pathway.
• The tablet should be taken whole; do not crush or chew for intended effect.
• Men with pigmentary retinopathy should use alternative treatments.
• Can be used in men with Parkinson's disease, with physician guidance.
• The drug's success led to reduced stigma around seeking help for ED.
• It does not increase the risk of prostate cancer or benign prostatic hyperplasia.
• Combining with other ED treatments (like injections) can cause severe priapism.
• The psychological boost from successful treatment can improve relationship dynamics.
• It is essential to purchase from licensed, accredited pharmacies only.
• Regular reevaluation of the need for medication is part of good medical practice.

use of potent cytochrome P450 3A4

• The 25 mg tablet is a tool, not a solution, for relationship issues related to ED.
• PDE5 inhibition leads to increased cyclic GMP, causing smooth muscle relaxation.
• Generic sildenafil must meet the same FDA standards for safety and efficacy.
• Taking with a high-fat meal can delay Tmax (time to peak concentration) by one hour.
• Men with cardiovascular disease need stress testing before sexual activity.
• The medication is metabolized primarily by the liver enzyme CYP3A4.
• Inhibitors of CYP3A4 (like some HIV drugs) can increase sildenafil levels.
• Inducers of CYP3A4 (like rifampin) can decrease sildenafil levels.
• Non-arteritic anterior ischemic optic neuropathy (NAION) is a potential risk.
• Patients with a history of NAION in one eye are at increased risk in the other.
• A urologist or primary care physician can provide a prescription.

inhibitors [ketoconazole, itraconazole, erythromycin (182%), saquinavir (210%)].

• The safety profile of 25 mg Viagra is well-studied with low incidence of serious side effects.
• Patients should schedule follow-up appointments to monitor response.
• It is important to consider interactions with medications like antihypertensives.
• Take note of any allergic reactions such as rash or swelling.
• Some men may achieve optimal results by adjusting the dose under supervision.
• Do not share Viagra with others, as it can cause adverse effects in certain individuals.
• Combining Viagra with nitrates can cause dangerous drops in blood pressure.